US$ 20.84
igf-1 lr3 muscle study Before and After: Results, Benefits and Timeline IGF‑1 LR3 for Beginners: Muscle
Description
Trials were excluded if they were single-armed, retrospective, non-randomized, enrolled patients with pre-existing peripheral neuropathy, enrolled patients not nave to chemotherapy, did not report outcomes specific to OIPN, or only reported acute OIPN outcomes

Wengenack TM, Curran GL, Poduslo JF

Cell viability was determined using a CCK-8 kit (Solarbio, Beijing China)

This product is not suitable for: Always consult a licensed healthcare professional before starting treatment
